세계의 예르시니아 진단 시장 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2031년)

Persistence Market Research has recently released a comprehensive report on the global Yersinia Diagnostics Market, providing an in-depth analysis of key market dynamics, including drivers, trends, opportunities, and challenges. This detailed report sheds light on the market structure and growth potential over the forecast period.

Key Insights:

• Yersinia Diagnostics Market Size (2024E): US$304.7 Million
• Projected Market Value (2031F): US$467.0 Million
• Global Market Growth Rate (CAGR 2024 to 2031): 6.3%

Yersinia Diagnostics Market - Report Scope:

Yersinia diagnostics encompasses various diagnostic methods for detecting Yersinia infections, such as Yersinia enterocolitica and Yersinia pestis, which cause diseases like yersiniosis and plague. The market is driven by the growing incidence of Yersinia infections, advancements in molecular diagnostic technologies, and the increasing demand for point-of-care testing (POCT) solutions.

Market Growth Drivers:

Several factors are driving the growth of the global Yersinia Diagnostics Market. The rising incidence of Yersinia-related diseases and the introduction of rapid diagnostic techniques such as polymerase chain reaction (PCR) and next-generation sequencing (NGS) are contributing to market expansion. Additionally, point-of-care testing devices are gaining traction for their ability to facilitate quick on-site detection of Yersinia pathogens in various healthcare settings.

Market Restraints:

Despite the growth prospects, the Yersinia Diagnostics Market faces several challenges. The variability of Yersinia strains and the complexity of diagnosing Yersinia infections across diverse patient groups create difficulties in developing accurate diagnostic tests. Cost constraints and limited access to advanced diagnostic tools in resource-limited settings also hinder market penetration.

Market Opportunities:

The Yersinia Diagnostics Market presents significant opportunities, especially with the rising demand for POCT devices and the emergence of precision medicine. Molecular diagnostics are increasingly being adopted for their higher sensitivity, specificity, and faster results. Additionally, collaborations with healthcare providers and the development of customized diagnostics for Yersinia infections are expected to drive market growth.

Key Questions Answered in the Report:

• What are the primary factors driving the global Yersinia Diagnostics Market?
• Which regions are witnessing the highest adoption of Yersinia diagnostics?
• How are advancements in diagnostic technologies impacting the competitive landscape?
• Who are the leading players in the Yersinia Diagnostics Market, and what strategies are they implementing to maintain their market positions?
• What are the emerging trends and future prospects in the global Yersinia Diagnostics Market?

Competitive Intelligence and Business Strategy:

Leading players in the Yersinia Diagnostics Market, including TestLine Clinical Diagnostics, T2 Biosystems, and Demeditec Diagnostics, are focusing on innovation, research and development, and strategic partnerships to strengthen their market positions. These companies are investing in the development of advanced diagnostic technologies such as PCR-based assays and multiplex tests to enhance the accuracy and speed of Yersinia diagnostics. Collaborations with public health agencies and research institutions are crucial for market penetration and sustained growth.

Key Companies Profiled:

• TestLine Clinical Diagnostics s.r.o
• CERTEST BIOTEC
• T2 Biosystems
• Demeditec Diagnostics GmbH
• Launch Diagnostics Limited
• ELITech Group
• Advanced Molecular Diagnostics
• SeraCare (LGC Clinical Diagnostics)
• Hygiena LLC
• Diagnostiki Athinon
• QED Bioscience Inc.
• BioFire Defense
• VIROTECH Diagnostics GmbH
• Thermo Fisher Scientific Inc.
• Seegene Inc.
• Diasorin S.p.A.

Yersinia Diagnostics Market - Segmentation

Product

• Instruments
• Kits and Reagents

Diagnostic Test

• Stool Culture
• Imaging Tests
• Serological Tests
• Colonoscopy
• Others

Technology

• Immunoassay
• DNA Probes
• Polymerase Chain Reaction (PCR)
• Flow Cytometry
• Chromatography
• Others

End Use

• Hospitals
• Public Health Laboratories
• Commercial Laboratories
• Others

Region

• North America
• Latin America
• Europe
• Middle East and Africa (MEA)
• East Asia
• South Asia
• Oceania

Table of Contents

1. Executive Summary

• 1.1. Global Yersinia Diagnostics Market Snapshot, 2024-2033
• 1.2. Market Opportunity Assessment, 2024-2033, US$ Mn
• 1.3. Key Market Trends
• 1.4. Future Market Projections
• 1.5. Premium Market Insights
• 1.6. Industry Developments and Key Market Events
• 1.7. PMR Analysis and Recommendations

2. Market Overview

• 2.1. Market Scope and Definition
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Opportunity
  • 2.2.4. Key Trends
• 2.3. Macro-Economic Factors
  • 2.3.1. Global Sectorial Outlook
  • 2.3.2. Global GDP Growth Outlook
  • 2.3.3. Global Healthcare Spending Outlook
• 2.4. COVID-19 Impact Analysis
• 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

• 3.1. Product Adoption Analysis
• 3.2. Disease Epidemiology
• 3.3. Technology Assessment
• 3.4. Regulatory Landscape
• 3.5. Supply Chain Analysis
• 3.6. Key Deals and Mergers
• 3.7. PESTLE Analysis
• 3.8. Porter's Five Force Analysis

4. Global Yersinia Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2033)

• 4.1. Key Highlights
  • 4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
  • 4.1.2. Absolute $ Opportunity
• 4.2. Market Size (US$ Mn) Analysis and Forecast
  • 4.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2023
  • 4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2024-2033
• 4.3. Global Yersinia Diagnostics Market Outlook: Product
  • 4.3.1. Introduction / Key Findings
  • 4.3.2. Historical Market Size (US$ Mn) Analysis, By Product, 2019-2023
  • 4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2033
    • 4.3.3.1. Instruments
    • 4.3.3.2. Kits and Reagents
• 4.4. Market Attractiveness Analysis: Product
• 4.5. Global Yersinia Diagnostics Market Outlook: Diagnostic Test
  • 4.5.1. Introduction / Key Findings
  • 4.5.2. Historical Market Size (US$ Mn) Analysis, By Diagnostic Test, 2019-2023
  • 4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2024-2033
    • 4.5.3.1. Stool Culture
    • 4.5.3.2. Imaging Tests
    • 4.5.3.3. Serological Tests
    • 4.5.3.4. Colonoscopy
    • 4.5.3.5. Others
• 4.6. Market Attractiveness Analysis: Diagnostic Test
• 4.7. Global Yersinia Diagnostics Market Outlook: Technology
  • 4.7.1. Introduction / Key Findings
  • 4.7.2. Historical Market Size (US$ Mn) Analysis, By Technology, 2019-2023
  • 4.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2033
    • 4.7.3.1. Immunoassay
    • 4.7.3.2. DNA Probes
    • 4.7.3.3. Polymerase Chain Reaction (PCR)
    • 4.7.3.4. Flow Cytometry
    • 4.7.3.5. Chromatography
    • 4.7.3.6. Others
• 4.8. Market Attractiveness Analysis: Technology
• 4.9. Global Yersinia Diagnostics Market Outlook: End User
  • 4.9.1. Introduction / Key Findings
  • 4.9.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2023
  • 4.9.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
    • 4.9.3.1. Hospitals
    • 4.9.3.2. Public Health Laboratories
    • 4.9.3.3. Commercial Laboratories
    • 4.9.3.4. Others
• 4.10. Market Attractiveness Analysis: End User

5. Global Yersinia Diagnostics Market Outlook: Region

• 5.1. Key Highlights
• 5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2023
• 5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2024-2033
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. East Asia
  • 5.3.4. South Asia and Oceania
  • 5.3.5. Latin America
  • 5.3.6. Middle East & Africa
• 5.4. Market Attractiveness Analysis: Region

6. North America Yersinia Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2033)

• 6.1. Key Highlights
• 6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
  • 6.2.1. By Country
  • 6.2.2. By Product
  • 6.2.3. By Diagnostic Test
  • 6.2.4. By Technology
  • 6.2.5. By End User
• 6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2033
  • 6.3.1. U.S.
  • 6.3.2. Canada
• 6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2033
  • 6.4.1. Instruments
  • 6.4.2. Kits and Reagents
• 6.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2024-2033
  • 6.5.1. Stool Culture
  • 6.5.2. Imaging Tests
  • 6.5.3. Serological Tests
  • 6.5.4. Colonoscopy
  • 6.5.5. Others
• 6.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2033
  • 6.6.1. Immunoassay
  • 6.6.2. DNA Probes
  • 6.6.3. Polymerase Chain Reaction (PCR)
  • 6.6.4. Flow Cytometry
  • 6.6.5. Chromatography
  • 6.6.6. Others
• 6.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
  • 6.7.1. Hospitals
  • 6.7.2. Public Health Laboratories
  • 6.7.3. Commercial Laboratories
  • 6.7.4. Others
• 6.8. Market Attractiveness Analysis

7. Europe Yersinia Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2033)

• 7.1. Key Highlights
• 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
  • 7.2.1. By Country
  • 7.2.2. By Product
  • 7.2.3. By Diagnostic Test
  • 7.2.4. By Technology
  • 7.2.5. By End User
• 7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2033
  • 7.3.1. Germany
  • 7.3.2. France
  • 7.3.3. U.K.
  • 7.3.4. Italy
  • 7.3.5. Spain
  • 7.3.6. Russia
  • 7.3.7. Turkiye
  • 7.3.8. Rest of Europe
• 7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2033
  • 7.4.1. Instruments
  • 7.4.2. Kits and Reagents
• 7.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2024-2033
  • 7.5.1. Stool Culture
  • 7.5.2. Imaging Tests
  • 7.5.3. Serological Tests
  • 7.5.4. Colonoscopy
  • 7.5.5. Others
• 7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2033
  • 7.6.1. Immunoassay
  • 7.6.2. DNA Probes
  • 7.6.3. Polymerase Chain Reaction (PCR)
  • 7.6.4. Flow Cytometry
  • 7.6.5. Chromatography
  • 7.6.6. Others
• 7.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
  • 7.7.1. Hospitals
  • 7.7.2. Public Health Laboratories
  • 7.7.3. Commercial Laboratories
  • 7.7.4. Others
• 7.8. Market Attractiveness Analysis

8. East Asia Yersinia Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2033)

• 8.1. Key Highlights
• 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
  • 8.2.1. By Country
  • 8.2.2. By Product
  • 8.2.3. By Diagnostic Test
  • 8.2.4. By Technology
  • 8.2.5. By End User
• 8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2033
  • 8.3.1. China
  • 8.3.2. Japan
  • 8.3.3. South Korea
• 8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2033
  • 8.4.1. Instruments
  • 8.4.2. Kits and Reagents
• 8.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2024-2033
  • 8.5.1. Stool Culture
  • 8.5.2. Imaging Tests
  • 8.5.3. Serological Tests
  • 8.5.4. Colonoscopy
  • 8.5.5. Others
• 8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2033
  • 8.6.1. Immunoassay
  • 8.6.2. DNA Probes
  • 8.6.3. Polymerase Chain Reaction (PCR)
  • 8.6.4. Flow Cytometry
  • 8.6.5. Chromatography
  • 8.6.6. Others
• 8.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
  • 8.7.1. Hospitals
  • 8.7.2. Public Health Laboratories
  • 8.7.3. Commercial Laboratories
  • 8.7.4. Others
• 8.8. Market Attractiveness Analysis

9. South Asia & Oceania Yersinia Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2033)

• 9.1. Key Highlights
• 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
  • 9.2.1. By Country
  • 9.2.2. By Product
  • 9.2.3. By Diagnostic Test
  • 9.2.4. By Technology
  • 9.2.5. By End User
• 9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2033
  • 9.3.1. India
  • 9.3.2. Southeast Asia
  • 9.3.3. ANZ
  • 9.3.4. Rest of South Asia & Oceania
• 9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2033
  • 9.4.1. Instruments
  • 9.4.2. Kits and Reagents
• 9.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2024-2033
  • 9.5.1. Stool Culture
  • 9.5.2. Imaging Tests
  • 9.5.3. Serological Tests
  • 9.5.4. Colonoscopy
  • 9.5.5. Others
• 9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2033
  • 9.6.1. Immunoassay
  • 9.6.2. DNA Probes
  • 9.6.3. Polymerase Chain Reaction (PCR)
  • 9.6.4. Flow Cytometry
  • 9.6.5. Chromatography
  • 9.6.6. Others
• 9.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
  • 9.7.1. Hospitals
  • 9.7.2. Public Health Laboratories
  • 9.7.3. Commercial Laboratories
  • 9.7.4. Others
• 9.8. Market Attractiveness Analysis

10. Latin America Yersinia Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2033)

• 10.1. Key Highlights
• 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
  • 10.2.1. By Country
  • 10.2.2. By Product
  • 10.2.3. By Diagnostic Test
  • 10.2.4. By Technology
  • 10.2.5. By End User
• 10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2033
  • 10.3.1. Brazil
  • 10.3.2. Mexico
  • 10.3.3. Rest of Latin America
• 10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2033
  • 10.4.1. Instruments
  • 10.4.2. Kits and Reagents
• 10.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2024-2033
  • 10.5.1. Stool Culture
  • 10.5.2. Imaging Tests
  • 10.5.3. Serological Tests
  • 10.5.4. Colonoscopy
  • 10.5.5. Others
• 10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2033
  • 10.6.1. Immunoassay
  • 10.6.2. DNA Probes
  • 10.6.3. Polymerase Chain Reaction (PCR)
  • 10.6.4. Flow Cytometry
  • 10.6.5. Chromatography
  • 10.6.6. Others
• 10.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
  • 10.7.1. Hospitals
  • 10.7.2. Public Health Laboratories
  • 10.7.3. Commercial Laboratories
  • 10.7.4. Others
• 10.8. Market Attractiveness Analysis

11. Middle East & Africa Yersinia Diagnostics Market Outlook: Historical (2019-2023) and Forecast (2024-2033)

• 11.1. Key Highlights
• 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2023
  • 11.2.1. By Country
  • 11.2.2. By Product
  • 11.2.3. By Diagnostic Test
  • 11.2.4. By Technology
  • 11.2.5. By End User
• 11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2024-2033
  • 11.3.1. GCC Countries
  • 11.3.2. Egypt
  • 11.3.3. South Africa
  • 11.3.4. Northern Africa
  • 11.3.5. Rest of Middle East & Africa
• 11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Product, 2024-2033
  • 11.4.1. Instruments
  • 11.4.2. Kits and Reagents
• 11.5. Current Market Size (US$ Mn) Analysis and Forecast, By Diagnostic Test, 2024-2033
  • 11.5.1. Stool Culture
  • 11.5.2. Imaging Tests
  • 11.5.3. Serological Tests
  • 11.5.4. Colonoscopy
  • 11.5.5. Others
• 11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Technology, 2024-2033
  • 11.6.1. Immunoassay
  • 11.6.2. DNA Probes
  • 11.6.3. Polymerase Chain Reaction (PCR)
  • 11.6.4. Flow Cytometry
  • 11.6.5. Chromatography
  • 11.6.6. Others
• 11.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2024-2033
  • 11.7.1. Hospitals
  • 11.7.2. Public Health Laboratories
  • 11.7.3. Commercial Laboratories
  • 11.7.4. Others
• 11.8. Market Attractiveness Analysis

12. Competition Landscape

• 12.1. Market Share Analysis, 2024
• 12.2. Market Structure
  • 12.2.1. Competition Intensity Mapping By Market
  • 12.2.2. Competition Dashboard
• 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 12.3.1. TestLine Clinical Diagnostics s.r.o
    • 12.3.1.1. Overview
    • 12.3.1.2. Segments and Products
    • 12.3.1.3. Key Financials
    • 12.3.1.4. Market Developments
    • 12.3.1.5. Market Strategy
  • 12.3.2. CERTEST BIOTEC
    • 12.3.2.1. Overview
    • 12.3.2.2. Segments and Products
    • 12.3.2.3. Key Financials
    • 12.3.2.4. Market Developments
    • 12.3.2.5. Market Strategy
  • 12.3.3. T2 Biosystems
    • 12.3.3.1. Overview
    • 12.3.3.2. Segments and Products
    • 12.3.3.3. Key Financials
    • 12.3.3.4. Market Developments
    • 12.3.3.5. Market Strategy
  • 12.3.4. Demeditec Diagnostics GmbH
    • 12.3.4.1. Overview
    • 12.3.4.2. Segments and Products
    • 12.3.4.3. Key Financials
    • 12.3.4.4. Market Developments
    • 12.3.4.5. Market Strategy
  • 12.3.5. Launch Diagnostics Limited
    • 12.3.5.1. Overview
    • 12.3.5.2. Segments and Products
    • 12.3.5.3. Key Financials
    • 12.3.5.4. Market Developments
    • 12.3.5.5. Market Strategy
  • 12.3.6. ELITech Group
    • 12.3.6.1. Overview
    • 12.3.6.2. Segments and Products
    • 12.3.6.3. Key Financials
    • 12.3.6.4. Market Developments
    • 12.3.6.5. Market Strategy
  • 12.3.7. Advanced Molecular Diagnostics
    • 12.3.7.1. Overview
    • 12.3.7.2. Segments and Products
    • 12.3.7.3. Key Financials
    • 12.3.7.4. Market Developments
    • 12.3.7.5. Market Strategy
  • 12.3.8. SeraCare (LGC Clinical Diagnostics)
    • 12.3.8.1. Overview
    • 12.3.8.2. Segments and Products
    • 12.3.8.3. Key Financials
    • 12.3.8.4. Market Developments
    • 12.3.8.5. Market Strategy
  • 12.3.9. Hygiena LLC
    • 12.3.9.1. Overview
    • 12.3.9.2. Segments and Products
    • 12.3.9.3. Key Financials
    • 12.3.9.4. Market Developments
    • 12.3.9.5. Market Strategy
  • 12.3.10. Diagnostiki Athinon
    • 12.3.10.1. Overview
    • 12.3.10.2. Segments and Products
    • 12.3.10.3. Key Financials
    • 12.3.10.4. Market Developments
    • 12.3.10.5. Market Strategy
  • 12.3.11. QED Bioscience Inc.
    • 12.3.11.1. Overview
    • 12.3.11.2. Segments and Products
    • 12.3.11.3. Key Financials
    • 12.3.11.4. Market Developments
    • 12.3.11.5. Market Strategy
  • 12.3.12. BioFire Defense
    • 12.3.12.1. Overview
    • 12.3.12.2. Segments and Products
    • 12.3.12.3. Key Financials
    • 12.3.12.4. Market Developments
    • 12.3.12.5. Market Strategy
  • 12.3.13. VIROTECH Diagnostics GmbH
    • 12.3.13.1. Overview
    • 12.3.13.2. Segments and Products
    • 12.3.13.3. Key Financials
    • 12.3.13.4. Market Developments
    • 12.3.13.5. Market Strategy
  • 12.3.14. Thermo Fisher Scientific Inc.
    • 12.3.14.1. Overview
    • 12.3.14.2. Segments and Products
    • 12.3.14.3. Key Financials
    • 12.3.14.4. Market Developments
    • 12.3.14.5. Market Strategy
  • 12.3.15. Seegene Inc.
    • 12.3.15.1. Overview
    • 12.3.15.2. Segments and Products
    • 12.3.15.3. Key Financials
    • 12.3.15.4. Market Developments
    • 12.3.15.5. Market Strategy
  • 12.3.16. Diasorin S.p.A.
    • 12.3.16.1. Overview
    • 12.3.16.2. Segments and Products
    • 12.3.16.3. Key Financials
    • 12.3.16.4. Market Developments
    • 12.3.16.5. Market Strategy

13. Appendix

• 13.1. Research Methodology
• 13.2. Research Assumptions
• 13.3. Acronyms and Abbreviations